Clin Endosc.  2014 Nov;47(6):560-563. 10.5946/ce.2014.47.6.560.

Esophgeal Perforation and Bilateral Empyema Following Endoscopic EsophyX Transoral Incisionless Fundoplication

• Edriss H
• El-Bakush
• Nugent K

• KMID: 2134495
• DOI: http://doi.org/10.5946/ce.2014.47.6.560

Abstract

Transoral incisionless fundoplication (TIF) has been used for endoscopic treatment of gastroesophageal reflux disease (GERD). TIF using the EsophyX device system (EndoGastric Solutions) was designed to create a full-thickness valve at the gastroesophageal junction through the insertion of multiple fasteners; it improves GERD, reduces proton pump inhibitor use, and improves quality of life. Although TIF is effective in select patients, a significant subset of patients undergoing TIF develop persistent or recurrent GERD symptoms and may need antireflux surgery to control the GERD symptoms. We now report a 48-year-old man with chronic GERD unresponsive to medical management. He underwent TIF complicated by esophageal perforation and developed mediastinitis, left pneumothorax, bilateral pleural effusions, and acute respiratory failure. He required chest tube placement and bilateral decortication for treatment of nonresolving empyemas. Additional postmarketing studies are required to assess the safety, efficacy, and clinical outcomes of this novel procedure, and patients undergoing this procedure need close postprocedural follow-up.

Keyword

Gastroesophageal reflux; Transoral incisionless fundoplication; Esophageal perforation; Empyema; Pneumothorax

MeSH Terms

Chest Tubes
Empyema*
Esophageal Perforation
Esophagogastric Junction
Fundoplication*
Gastroesophageal Reflux
Humans
Mediastinitis
Middle Aged
Pleural Effusion
Pneumothorax
Proton Pumps
Quality of Life
Respiratory Insufficiency
Proton Pumps

Figure

• 

  Fig. 1 Computed tomography of the chest shows bilateral pleural effusions greater on the left side (arrow A), pneumomediastinum (arrow B), and anterior left-sided pneumothorax (arrow C). There are compressed and atelectatic lungs at both lung bases.

• 

  Fig. 2 (A) Transoral incisionless fundoplication procedure with gastrogastric plications placed at the Z-line level. (B) The technique creates an esophagogastric fundoplication proximal to the Z-line. (C, D) Scope withdrawal. This creates partially circumferential fundoplication made of gastric tissue. Available under the terms of a Creative Commons Attribution Noncommercial License. Accessed from Open i beta, TTUHSC Health Sciences Center Library on October 16, 2013. Adapted from Bell et al. Surg Endosc 2011;25:2387-2399, with permission from Springer.11

Reference

1. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R. Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006; 101:1900–1920. PMID: 16928254.

2. Tytgat GN, McColl K, Tack J, et al. New algorithm for the treatment of gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2008; 27:249–256. PMID: 17973975.

3. Triadafilopoulos G. Endotherapy and surgery for GERD. J Clin Gastroenterol. 2007; 41(Suppl 2):S87–S96. PMID: 17575537.

4. Witteman BP, Strijkers R, de Vries E, et al. Transoral incisionless fundoplication for treatment of gastroesophageal reflux disease in clinical practice. Surg Endosc. 2012; 26:3307–3315. PMID: 22648098.

5. Cadière GB, Buset M, Muls V, et al. Antireflux transoral incisionless fundoplication using EsophyX: 12-month results of a prospective multicenter study. World J Surg. 2008; 32:1676–1688. PMID: 18443855.

6. Ihde GM, Besancon K, Deljkich E. Short-term safety and symptomatic outcomes of transoral incisionless fundoplication with or without hiatal hernia repair in patients with chronic gastroesophageal reflux disease. Am J Surg. 2011; 202:740–746. PMID: 22014853.

7. Narsule CK, Wee JO, Fernando HC. Endoscopic management of gastroesophageal reflux disease: a review. J Thorac Cardiovasc Surg. 2012; 144:S74–S79. PMID: 22513318.

8. Bell RC, Mavrelis PG, Barnes WE, et al. A prospective multicenter registry of patients with chronic gastroesophageal reflux disease receiving transoral incisionless fundoplication. J Am Coll Surg. 2012; 215:794–809. PMID: 22939637.

9. Muls V, Eckardt AJ, Marchese M, et al. Three-year results of a multicenter prospective study of transoral incisionless fundoplication. Surg Innov. 2013; 20:321–330. PMID: 22968006.

10. Hoppo T, Immanuel A, Schuchert M, et al. Transoral incisionless fundoplication 2.0 procedure using EsophyX for gastroesophageal reflux disease. J Gastrointest Surg. 2010; 14:1895–1901. PMID: 20878257.

11. Bell RC, Cadière GB. Transoral rotational esophagogastric fundoplication: technical, anatomical, and safety considerations. Surg Endosc. 2011; 25:2387–2399. PMID: 21184101.

12. Narsule CK, Burch MA, Ebright MI, et al. Endoscopic fundoplication for the treatment of gastroesophageal reflux disease: initial experience. J Thorac Cardiovasc Surg. 2012; 143:228–234. PMID: 22070927.

13. Velanovich V. Endoscopic, endoluminal fundoplication for gastroesophageal reflux disease: initial experience and lessons learned. Surgery. 2010; 148:646–651. PMID: 20708763.

14. Agostoni M, Boemo C. Bilateral pneumothorax during transoral incisionless fundoplication. Eur J Anaesthesiol. 2010; 27:216–217. PMID: 19935074.

15. Trad KS, Turgeon DG, Deljkich E. Long-term outcomes after transoral incisionless fundoplication in patients with GERD and LPR symptoms. Surg Endosc. 2012; 26:650–660. PMID: 21959689.

16. Testoni PA, Vailati C. Transoral incisionless fundoplication with EsophyX(R) for treatment of gastro-oesphageal reflux disease. Dig Liver Dis. 2012; 44:631–635. PMID: 22622203.